Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |